NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
Abroad (travel likely)RecruitingPHASE2
Conditions
Anaplastic Thyroid Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ellen Kapiteijn, Leiden, South Holland, Netherlands
Study leads
Ellen Kapiteijn, MD, PhD
Principal Investigator
Leiden University Medical Center